UCSF

Lisa Kroon, PharmD

Chair and Professor
Department of Clinical Pharmacy
Kroon
Credit: 
Susan Merrell, UCSF
[email protected]
Phone: +1 415 476-1687
Fax: +1 415 476-6632
533 Parnassus Avenue, Rm 501
San Francisco, CA 94143
United States

Links

Rx for Change
UCSF Profiles
Tobacco Treatment Center

Educational programs

UCSF centers, institutes, and research programs

Executive Director, Medication Outcomes Center

What I do

I am the chair of the Department of Clinical Pharmacy and am responsible for setting the strategic direction, priorities, and goals for the department. I continue to be involved in teaching in the Doctor of Pharmacy curriculum and in interprofessional education at UCSF, and I also provide clinical service.

Departmental research area

Clinical research

My research expertise

Pharmacy-based smoking cessation services and interventions, Testing innovative pharmacy programs in the community pharmacy setting, Diabetes therapeutics

Clinical expertise

Adult diabetes, Tobacco and smoking cessation

Degrees

Pharmacy Practice Residency, Hospital Pharmacy Administration, University of California, San Francisco, 1996
Pharmacy Practice Residency, University of California, San Francisco, 1995
PharmD, University of Michigan, 1994

Biography

Dr. Lisa Kroon is a Professor and Chair of the Department of Clinical Pharmacy in the School of Pharmacy at the University of California in San Francisco. Dr. Kroon received her Doctor of Pharmacy at the University of Michigan and then completed two years of residency at UCSF in pharmacy practice and hospital pharmacy administration. She has been a member of the UCSF faculty since 1996. She practices in the UCSF Medical Center’s Adult Diabetes Clinic and Diabetes Teaching Center, where she cares for people with diabetes and chronic illnesses. She co-directs the Fontana Tobacco Treatment Center (www.ucsfhealth.org/tobaccotreatment). Her current research interests include interprofessional health education, tobacco cessation, and innovative practice models in the community pharmacy setting.

Research keywords

drug interactions, Hypoglycemic Agents, Type 2 Diabetes Mellitus, Injections, Subcutaneous, pharmacies

Licensure and certifications

Licentiate in Pharmacy, California, 1995
Certified Diabetes Educator, 1999
1. Update from the Dean – July 2018
2. The epic journey to better medicines
3. Update from the Dean – March 2018
4. Advanced practice pharmacists are ready
5. Kroon, Stebbins, and Clark offer guidance on hospital care
6. Class of 2020 student pharmacists don their white coats
7. Kroon named Fellow of the American Pharmacists Association
8. Label warnings, antibiotic measurements, cancer therapies, and smoking interventions take top honors at annual seminar
9. Brodowy named director of UCSF Medication Outcomes Center
10. UCSF School of Pharmacy adopts broad recommendation on tobacco
11. Lisa Kroon named chair of the UCSF Department of Clinical Pharmacy
12. School to train Safeway pharmacists in smoking cessation counseling
13. UCSF Pharmacy Faculty Advocate for Legislation Banning Tobacco Sales in Pharmacies
14. Pharmacist Serves Deaf and Hard of Hearing Community
1. Apple for Teachers Award for Excellence in Teaching, UCSF School of Pharmacy, 2013
2. Advisor of the Year, Academy of Students of Pharmacy, UCSF Chapter, 2012
3. Outstanding Teacher of the Year, San Francisco Program, Long Award for Excellence in Teaching, UCSF School of Pharmacy, 2012
4. Best Practices Award, Academy of Pharmacy Educators, California Pharmacists Association, 2011
5. Apple for Teachers Award for Excellence in Teaching, UCSF School of Pharmacy, 2009-2010
6. Preceptor of the Year, Academy of Students of Pharmacy, UCSF Chapter, 2003-2004
7. Practioner Fellow, California Society of Health-System Pharmacists, 2002
8. Elected into Phi Lambda Sigma, an honorary pharmacy leadership society, Phi Lambda Sigma, 1998
9. Member, Rho Chi Pharmacy Honor Society, 1992

Publications

Wilson L, Lin T, Wang L, Patel T, Tran D, Kim S, Dacey K, Yuen C, Kroon L, Brodowy B, Rodondi K. Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center. J Manag Care Spec Pharm. 2017 Feb; 23(2):163-169.
Kroon LA, Corelli RL, Roth AP, Hudmon KS. Public perceptions of the ban on tobacco sales in San Francisco pharmacies. Tob Control. 2013 Nov; 22(6):369-71.
Nam S, Janson SL, Stotts NA, Chesla C, Kroon L. Effect of culturally tailored diabetes education in ethnic minorities with type 2 diabetes: a meta-analysis. J Cardiovasc Nurs. 2012 Nov-Dec; 27(6):505-18.
Wamsley M, Staves J, Kroon L, Topp K, Hossaini M, Newlin B, Lindsay C, O'Brien B. The impact of an interprofessional standardized patient exercise on attitudes toward working in interprofessional teams. J Interprof Care. 2012 Jan; 26(1):28-35.
Kroon L. An analysis of dosage volume for halfway doses in the Victoza Pen. J Diabetes Sci Technol. 2011 Nov 01; 5(6):1625-6.
Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011 Jul; 93(1):1-9.
Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010 Aug; 33(8):1747-9.
Potter MB, Gildengorin G, Wang Y, Wu M, Kroon L. Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign. J Am Pharm Assoc (2003). 2010 Mar-Apr 1; 50(2):181-7.
Kroon L. An analysis of patient acceptance and safety of a prefilled insulin injection device. J Diabetes Sci Technol. 2009 Nov 01; 3(6):1439-41.
Janson SL, Cooke M, McGrath KW, Kroon LA, Robinson S, Baron RB. Improving chronic care of type 2 diabetes using teams of interprofessional learners. Acad Med. 2009 Nov; 84(11):1540-8.
Kroon L. Overview of insulin delivery pen devices. J Am Pharm Assoc (2003). 2009 Sep-Oct; 49(5):e118-31.
Corelli RL, Fenlon CM, Kroon LA, Prokhorov AV, Hudmon KS. Evaluation of a train-the-trainer program for tobacco cessation. Am J Pharm Educ. 2007 Dec 15; 71(6):109.
Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007 Sep 15; 64(18):1917-21.
Kroon LA. Drug interactions and smoking: raising awareness for acute and critical care providers. Crit Care Nurs Clin North Am. 2006 Mar; 18(1):53-62, xii.
Irons BK, Kroon LA. Lipid management with statins in type 2 diabetes mellitus. Ann Pharmacother. 2005 Oct; 39(10):1714-9.
Corelli RL, Kroon LA, Chung EP, Sakamoto LM, Gundersen B, Fenlon CM, Hudmon KS. Statewide evaluation of a tobacco cessation curriculum for pharmacy students. Prev Med. 2005 Jun; 40(6):888-95.
Hudmon KS, Bardel K, Kroon LA, Fenlon CM, Corelli RL. Tobacco education in U.S. schools of pharmacy. Nicotine Tob Res. 2005 Apr; 7(2):225-32.
Hudmon KS, Kroon LA, Corelli RL, Saunders KC, Spitz MR, Bates TR, Liang D. Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):477-81.
Hudmon KS, Hemberger KK, Corelli RL, Kroon LA, Prokhorov AV. The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy. J Am Pharm Assoc (2003). 2003 Sep-Oct; 43(5):573-82.
Hudmon KS, Corelli RL, Chung E, Gundersen B, Kroon LA, Sakamoto LM, Hemberger KK, Fenlon C, Prokhorov AV. Development and implementation of a tobacco cessation training program for students in the health professions. J Cancer Educ. 2003; 18(3):142-9.
Assemi M, Torres NM, Tsourounis C, Kroon LA, McCart GM. Assessment of an online consumer "Ask Your Pharmacist" service. Ann Pharmacother. 2002 May; 36(5):787-92.
Make a gift
We see a time when precise therapeutics—used safely and effectively—improve the health of people everywhere.
© 2002–2019 The Regents of the University of California